Pacira Biosciences
PCRX
#5836
Rank
A$1.62 B
Marketcap
A$36.12
Share price
0.04%
Change (1 day)
19.95%
Change (1 year)
Categories

Pacira Biosciences (PCRX) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.95 Billion

According to Pacira Biosciences 's latest financial reports the company's total assets are A$1.95 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Pacira Biosciences - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$2.49 B8.08%
2023-12-31A$2.31 B-6.46%
2022-12-31A$2.47 B-13.7%
2021-12-31A$2.86 B72.71%
2020-12-31A$1.65 B39.64%
2019-12-31A$1.18 B21.3%
2018-12-31A$0.97 B21.58%
2017-12-31A$0.80 B48.21%
2016-12-31A$0.54 B2.04%
2015-12-31A$0.53 B33.59%
2014-12-31A$0.39 B109.27%
2013-12-31A$0.19 B76.56%
2012-12-31A$0.10 B-2.58%
2011-12-31A$0.11 B68.91%
2010-12-31A$65.52 M33.92%
2009-12-31A$48.92 M-31.7%
2008-12-31A$71.63 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Recro Pharma
REPH
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
A$65.98 M-96.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
A$0.37 B-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A$0.30 B-84.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA